| [1] |
Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults[J]. Circulation, 2017, 135(8): 759-771. DOI: 10.1161/CIRCULATIONAHA.116.025250.
|
| [2] |
|
| [3] |
Petrovic-Djergovic D, Goonewardena SN, Pinsky DJ. Inflammatory disequili-brium in stroke[J]. Circ Res. 2016, 119(1): 142-158. DOI: 10.1161/CIRCRESAHA.116.308022.
|
| [4] |
|
| [5] |
Lim KH, Staudt LM. Toll-like receptor signaling[J]. Cold Spring Harb Perspect Biol, 2013, 5(1): a011247. DOI: 10.1101/cshperspect.a011247.
|
| [6] |
Wang Y, Ge P, Zhu Y. TLR2 and TLR4 in the brain injury caused by cerebral ischemia and reperfusion[J]. Mediators Inflamm, 2013, 2013: 124614. DOI: 10.1155/2013/124614.
|
| [7] |
Hakimizadeh E, Shamsizadeh A, Roohbakhsh A, et al. TRPV1 receptor-mediated expression of Toll-like receptors 2 and 4 following permanent middle cerebral artery occlusion in rats[J]. Iran J Basic Med Sci, 2017, 20(8): 863-869. DOI: 10.22038/IJBMS.2017.9107.
|
| [8] |
Sameer AS, Nissar S. Toll-like receptors (TLRs): structure, functions, signaling, and role of their polymorphisms in colorectal cancer susceptibility[J]. Biomed Res Int, 2021, 2021: 1157023. DOI: 10.1155/2021/1157023.
|
| [9] |
Zhang X, Hei Y, Bai W, et al. Toll-like receptor 2 attenuates traumatic brain injury-induced neural stem cell proliferation in dentate gyrus of rats[J]. Neural Plast, 2020, 2020: 9814978. DOI: 10.1155/2020/9814978.
|
| [10] |
Dutta D, Jana M, Majumder M, et al. Selective targeting of the TLR2/MyD88/NF-κB pathway reduces α-synuclein spreading in vitro and in vivo[J]. Nat Commun, 2021, 12(1): 5382. DOI: 10.1038/s41467-021-25767-1.
|
| [11] |
Zhao H, Lv J, Meng L, et al. Dual-specificity phosphatase 26-dificient neurons are susceptible to oxygen-glucose deprivation/reoxygenation-evoked apoptosis and proinflammatory response by affecting the TAK1-medaited JNK/P38 MAPK pathway[J]. Int Immunopharmacol, 2023, 117: 109980. DOI: 10.1016/j.intimp.2023.109980.
|
| [12] |
Köllisch G, Kalali BN, Voelcker V, et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes[J]. Immunology, 2005, 114(4): 531-541. DOI: 10.1111/j.1365-2567.2005.02122.x.
|
| [13] |
Roshan MH, Tambo A, Pace NP. The role of TLR2, TLR4, and TLR9 in the pathogenesis of atherosclerosis[J]. Int J Inflam, 2016, 2016: 1532832. DOI: 10.1155/2016/1532832.
|
| [14] |
|
| [15] |
Arya P, Bhandari U. Involvement of the toll-like receptors-2/nuclear factor-kappa B signaling pathway in atherosclerosis induced by high-fat diet and zymosan a in C57BL/6 mice[J]. Indian J Pharmacol, 2020, 52(3): 203-209. DOI: 10.4103/ijp.IJP_567_19.
|
| [16] |
|
| [17] |
Kurzepa J, Kurzepa J, Golab P, et al. The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke[J]. Int J Neurosci, 2014, 124(10): 707-716. DOI: 10.3109/00207454.2013.872102.
|
| [18] |
Zhu H, Dai R, Fu H, et al. MMP-9 upregulation is attenuated by the monoclonal TLR2 antagonist T2.5 after oxygen-glucose deprivation and reoxygenation in rat brain microvascular endothelial cells[J]. J Stroke Cerebrovasc Dis, 2019, 28(1): 97-106. DOI: 10.1016/j.jstrokecerebrovasdis.2018.09.014.
|
| [19] |
Huang H, Zhong R, Xia Z, et al. Neuroprotective effects of rhynchophylline against ischemic brain injury via regulation of the Akt/mTOR and TLRs signaling pathways[J]. Molecules, 2014, 19(8): 11196-11210. DOI: 10.3390/molecules190811196.
|
| [20] |
Sun W, Ding Z, Xu S, et al. Crosstalk between TLR2 and Sphk1 in microglia in the cerebral ischemia/reperfusion-induced inflammatory response[J]. Int J Mol Med, 2017, 40(6): 1750-1758. DOI: 10.3892/ijmm.2017.3165.
|
| [21] |
Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation[J]. Nat Med, 2011, 17(7): 796-808. DOI: 10.1038/nm.2399.
|
| [22] |
Ziegler G, Harhausen D, Schepers C, et al. TLR2 has a detrimental role in mouse transient focal cerebral ischemia[J]. Biochem Biophys Res Commun, 2007, 359(3): 574-579. DOI: 10.1016/j.bbrc.2007.05.157.
|
| [23] |
Zhang P, Cheng G, Chen L, et al. Cerebral hypoxia-ischemia increases toll-like receptor 2 and 4 expression in the hippocampus of neonatal rats[J]. Brain Dev, 2015, 37(8): 747-752. DOI: 10.1016/j.braindev.2014.12.001.
|
| [24] |
Anttila JE, Whitaker KW, Wires ES, et al. Role of microglia in ischemic focal stroke and recovery: focus on Toll-like receptors[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2017, 79(Pt A): 3-14. DOI: 10.1016/j.pnpbp.2016.07.003.
|
| [25] |
Huang Y, Cai B, Xu M, et al. Gene silencing of Toll-like receptor 2 inhibits proliferation of human liver cancer cells and secretion of inflammatory cytokines [J]. PLoS One, 2012, 7(7): e38890. DOI: 10.1371/journal.pone.0038890.
|
| [26] |
Nalamolu KR, Challa SR, Fornal CA, et al. Attenuation of the induction of TLRs 2 and 4 mitigates inflammation and promotes neurological recovery after focal cerebral ischemia[J]. Transl Stroke Res, 2021, 12(5): 923-936. DOI: 10.1007/s12975-020-00884-z.
|
| [27] |
|
| [28] |
Brea D, Blanco M, Ramos-Cabrer P, et al. Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values[J]. J Cereb Blood Flow Metab, 2011, 31(6): 1424-1431. DOI: 10.1038/jcbfm.2010.231.
|
| [29] |
Bohacek I, Cordeau P, Lalancette-Hébert M, et al. Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury[J]. J Neuroinflammation, 2012, 9: 191. DOI: 10.1186/1742-2094-9-191.
|
| [30] |
|
| [31] |
Moon S, Chang MS, Koh SH, et al. Repair mechanisms of the neurovascular unit after ischemic stroke with a focus on VEGF[J]. Int J Mol Sci, 2021, 22(16): 8543. DOI: 10.3390/ijms22168543.
|
| [32] |
|
| [33] |
Qiu Y, Yin Q, Fei Y, et al. JLX001 modulated the inflammatory reaction and oxidative stress in pMCAO rats via inhibiting the TLR2/4-NF-κB signaling pathway[J]. Neurochem Res, 2019, 44(8): 1924-1938. DOI: 10.1007/s11064-019-02826-0.
|
| [34] |
Ling Y, Jin L, Ma Q, et al. Salvianolic acid a alleviated inflammatory response mediated by microglia through inhibiting the activation of TLR2/4 in acute cerebral ischemia-reperfusion[J]. Phytomedicine, 2021, 87: 153569. DOI: 10.1016/j.phymed.2011.153569.
|
| [35] |
Huang L, Chen C, Zhang X, et al. Neuroprotective effect of curcumin against cerebral ischemia-reperfusion Via mediating autophagy and inflammation[J]. J Mol Neurosci, 2018, 64(1): 129-139. DOI: 10.1007/s12031-017-1006-x.
|
| [36] |
Tu XK, Yang WZ, Shi SS, et al. Baicalin inhibits TLR2/4 signaling pathway in rat brain following permanent cerebral ischemia[J]. Inflammation, 2011, 34(5): 463-470. DOI: 10.1007/s10753-010-9254-8.
|
| [37] |
Gad SN, Nofal S, Raafat EM, et al. Lixisenatide reduced damage in hippocampus CA1 neurons in a rat model of cerebral ischemia-reperfusion possibly via the ERK/P38 signaling pathway[J]. J Mol Neurosci, 2020, 70(7): 1026-1037. DOI: 10.1007/s12031-020-01497-9.
|
| [38] |
Chen X, Arumugam TV, Cheng YL, et al. Combination therapy with low-dose IVIG and a C1-esterase inhibitor ameliorates brain damage and functional deficits in experimental ischemic stroke[J]. Neuromolecular Med, 2018, 20(1): 6372. DOI: 10.1007/s12017-017-8474-6.
|
| [39] |
Xu XJ, Long JB, Jin KY, et al. Danshen-Chuanxiongqin injection attenuates cerebral ischemic stroke by inhibiting neuroinflammation via the TLR2/TLR4-MyD88-NF-κB pathway in tMCAO mice[J]. Chin J Nat Med, 2021, 19(10): 772-783. DOI: 10.1016/S1875-5364(21)60083-3.
|
| [40] |
Xie W, Zhou P, Sun Y, et al. Protective effects and target network analysis of ginsenoside Rg1 in cerebral ischemia and reperfusion injury: a comprehensive overview of experimental studies[J]. Cells, 2018, 7(12): 270. DOI: 10.3390/cells7120270.
|
| [41] |
Chen H, Guan B, Wang B, et al. Glycyrrhizin prevents hemorrhagic transformation and improves neurological outcome in ischemic stroke with delayed thromb-olysis through targeting peroxynitrite-mediated HMGB1 signaling[J]. Transl Stroke Res, 2020, 11(5): 967-982. DOI: 10.1007/s12975-019-00772-1.
|
| [42] |
|
| [43] |
|
| [44] |
Tajalli-Nezhad S, Karimian M, Beyer C, et al. The regulatory role of Toll-like receptors after ischemic stroke: neurosteroids as TLR modulators with the focus on TLR2/4[J]. Cell Mol Life Sci, 2019, 76(3): 523-537. DOI: 10.1007/s00018-018-2953-2.
|
| [45] |
|
| [46] |
Hu H, Zou C. Mesenchymal stem cells in renal ischemia-reperfusion injury: biological and therapeutic perspectives[J]. Curr Stem Cell Res Ther, 2017, 12(3): 183-187. DOI: 10.2174/1574888X11666161024143640.
|
| [47] |
|
| [48] |
黄伟,李佳,朱广为.针刺百会、人中穴对急性脑缺血大鼠模型NF-κB/IκB-α的影响[J].中华中医药杂志, 2017, 32(1): 298-302.
|
| [49] |
Lee HI, Lee SW, Kim NG, et al. Low-level light emitting diode (LED) therapy suppresses inflammasome-mediated brain damage in experimental ischemic stroke[J]. J Biophotonics, 2017, 10(11): 1502-1513. DOI: 10.1002/jbio.201600244.
|
| [50] |
Ma W, Xie X, Shao X, et al. Tetrahedral DNA nanostructures facilitate neural stem cell migration via activating RHOA/ROCK2 signalling pathway[J]. Cell Prolif, 2018, 51(6): e12503. DOI: 10.1111/cpr.12503.
|
| [51] |
Ma W, Zhan Y, Zhang Y, et al. Enhanced neural regeneration with a concomitant treatment of framework nucleic acid and stem cells in spinal cord injury[J]. ACS Appl Mater Interfaces, 2020, 12(2): 2095-2106. DOI: 10.1021/acsami.9b19079.
|
| [52] |
Zhou M, Zhang T, Zhang B, et al. A DNA nanostructure-based neuroprotectant against neuronal apoptosis via inhibiting Toll-like receptor 2 signaling pathway in acute ischemic stroke[J]. ACS Nano, 2022, 16(1): 1456-1470. DOI: 10.1021/acsnano.1c09626.
|